Literature DB >> 12960614

On the correlation between local fibrinolytic activity in menstrual fluid and total blood loss during menstruation and effects of desmopressin.

Måns Edlund1, Margareta Blombäck, Shu He.   

Abstract

The primary objective of this study was to investigate the correlation between fibrinolytic activity in menstrual fluid and total menstrual blood loss during menstruation. We also wanted to evaluate the influence of desmopressin nasal inhalation on the local fibrinolytic activity in menstrual fluid. Six women with objectively verified menorrhagia and six women with normal menstrual blood loss were examined. With a slender catheter introduced through the cervical canal, menstrual fluid was collected on the day in the cycle when the most intense bleeding occurred. The fibrinolytic activity in menstrual fluid was measured both as plasmin content using an amidolytic method with chromogenic substrate and with a fibrin plate method. A significant correlation between the amount of menstrual blood loss and fibrinolytic activity was found in menstrual fluid of both groups and with both methods. We could not find an increased fibrinolytic activity in menstrual fluid when the women with menorrhagia were treated with desmopressin nasal inhalation. Knowledge of the local factors influencing monthly blood loss can be valuable when searching for more effective medical treatment of menorrhagia. Apprehension that desmopressin should increase local fibrinolytic activity in menstrual fluid could not be confirmed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12960614     DOI: 10.1097/00001721-200309000-00012

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


  5 in total

1.  Phase II prospective open-label trial of recombinant interleukin-11 in women with mild von Willebrand disease and refractory menorrhagia.

Authors:  Margaret V Ragni; Rachel C Jankowitz; Kristen Jaworski; Elizabeth P Merricks; Mark T Kloos; Timothy C Nichols
Journal:  Thromb Haemost       Date:  2011-08-11       Impact factor: 5.249

Review 2.  A benefit-risk review of systemic haemostatic agents: part 2: in excessive or heavy menstrual bleeding.

Authors:  Ian S Fraser; Robert J Porte; Peter A Kouides; Andrea S Lukes
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

Review 3.  Endometrial haemostasis and menstruation.

Authors:  Joanna Davies; Rezan A Kadir
Journal:  Rev Endocr Metab Disord       Date:  2012-12       Impact factor: 6.514

Review 4.  Antifibrinolytics for heavy menstrual bleeding.

Authors:  Alison C Bryant-Smith; Anne Lethaby; Cindy Farquhar; Martha Hickey
Journal:  Cochrane Database Syst Rev       Date:  2018-04-15

5.  Interventions commonly available during pandemics for heavy menstrual bleeding: an overview of Cochrane Reviews.

Authors:  Magdalena Bofill Rodriguez; Anne Lethaby; Cindy Farquhar; James Mn Duffy
Journal:  Cochrane Database Syst Rev       Date:  2020-07-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.